A detailed history of Hutchinson Capital Management transactions in Pfizer Inc stock. As of the latest transaction made, Hutchinson Capital Management holds 34,104 shares of PFE stock, worth $936,495. This represents 0.21% of its overall portfolio holdings.

Number of Shares
34,104
Previous 34,903 2.29%
Holding current value
$936,495
Previous $968,000 1.45%
% of portfolio
0.21%
Previous 0.21%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$25.26 - $29.6 $20,182 - $23,650
-799 Reduced 2.29%
34,104 $954,000
Q1 2024

May 06, 2024

SELL
$25.89 - $29.73 $23,741 - $27,262
-917 Reduced 2.56%
34,903 $968,000
Q4 2023

Feb 07, 2024

SELL
$26.13 - $33.94 $34,125 - $44,325
-1,306 Reduced 3.52%
35,820 $1.03 Million
Q3 2023

Nov 09, 2023

SELL
$32.09 - $37.51 $13,927 - $16,279
-434 Reduced 1.16%
37,126 $1.23 Million
Q2 2023

Jul 25, 2023

SELL
$36.12 - $41.79 $76,466 - $88,469
-2,117 Reduced 5.34%
37,560 $1.38 Million
Q1 2023

May 04, 2023

SELL
$39.39 - $51.28 $4,923 - $6,410
-125 Reduced 0.31%
39,677 $1.62 Million
Q4 2022

Feb 13, 2023

SELL
$41.75 - $54.5 $67,885 - $88,617
-1,626 Reduced 3.92%
39,802 $2.04 Million
Q3 2022

Oct 31, 2022

BUY
$43.76 - $53.42 $2,625 - $3,205
60 Added 0.15%
41,428 $1.81 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $35,688 - $42,315
767 Added 1.89%
41,368 $2.17 Million
Q1 2022

May 11, 2022

SELL
$45.75 - $56.69 $175,085 - $216,952
-3,827 Reduced 8.61%
40,601 $2.1 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $145,115 - $215,110
-3,512 Reduced 7.33%
44,428 $2.62 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $13,816 - $17,747
-352 Reduced 0.73%
47,940 $2.06 Million
Q2 2021

Aug 12, 2021

SELL
$35.91 - $40.68 $11,993 - $13,587
-334 Reduced 0.69%
48,292 $1.89 Million
Q1 2021

May 07, 2021

BUY
$33.49 - $37.77 $53,584 - $60,432
1,600 Added 3.4%
48,626 $1.76 Million
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $28,114 - $35,750
840 Added 1.82%
47,026 $1.73 Million
Q3 2020

Nov 13, 2020

SELL
$31.75 - $37.25 $1,682 - $1,974
-53 Reduced 0.11%
46,186 $1.7 Million
Q2 2020

Aug 11, 2020

SELL
$30.12 - $36.54 $129,516 - $157,122
-4,300 Reduced 8.51%
46,239 $1.51 Million
Q1 2020

May 13, 2020

SELL
$27.03 - $38.62 $66,142 - $94,503
-2,447 Reduced 4.62%
50,539 $1.65 Million
Q4 2019

Feb 05, 2020

BUY
$32.92 - $37.36 $132,503 - $150,374
4,025 Added 8.22%
52,986 $2.08 Million
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $6,400 - $8,299
197 Added 0.4%
48,961 $1.76 Million
Q2 2019

Aug 06, 2019

SELL
$36.98 - $41.52 $53,362 - $59,913
-1,443 Reduced 2.87%
48,764 $2.11 Million
Q1 2019

May 06, 2019

SELL
$37.5 - $41.2 $11,962 - $13,142
-319 Reduced 0.63%
50,207 $2.13 Million
Q4 2018

Jan 30, 2019

SELL
$38.47 - $43.86 $16,349 - $18,640
-425 Reduced 0.83%
50,526 $2.21 Million
Q3 2018

Oct 31, 2018

SELL
$34.47 - $41.81 $24,611 - $29,852
-714 Reduced 1.38%
50,951 $2.25 Million
Q2 2018

Aug 08, 2018

SELL
$32.98 - $35.16 $14,412 - $15,364
-437 Reduced 0.84%
51,665 $1.87 Million
Q4 2017

Feb 09, 2018

SELL
$33.26 - $35.29 $16,763 - $17,786
-504 Reduced 0.96%
52,102 $1.89 Million
Q3 2017

Oct 30, 2017

BUY
$31.0 - $34.15 $1.63 Million - $1.8 Million
52,606
52,606 $1.88 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Hutchinson Capital Management Portfolio

Follow Hutchinson Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hutchinson Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Hutchinson Capital Management with notifications on news.